High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients

(2011) Martha T van der Beek et al.   ANTIVIRAL THERAPY

An International Comparison of Current Strategies to Prevent Herpesvirus and Fungal Infections in Hematopoietic Cell Transplant Recipients

(2010) Margaret Pollack et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

(2010) S. Hantz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

How we treat cytomegalovirus in hematopoietic cell transplant recipients

(2009) M. Boeckh et al.   BLOOD

Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus

(2009) T. Allice et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Haploidentical hematopoietic cell transplantation

(2008) L-P Koh et al.   BONE MARROW TRANSPLANTATION

Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation

(2008) Michael Y. Shapira et al.   CLINICAL INFECTIOUS DISEASES